Sanara MedTech Inc. SMTI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 91.96% | -222.15% | -193.82% | -288.66% | -348.29% |
| Total Depreciation and Amortization | 14.19% | -6.96% | -17.27% | -23.95% | -50.59% |
| Total Amortization of Deferred Charges | 10.69% | 21.79% | 10.65% | 33.56% | 73.26% |
| Total Other Non-Cash Items | -71.32% | 274.60% | 336.88% | 490.89% | 867.63% |
| Change in Net Operating Assets | -455.40% | -851.82% | -62.20% | 206.74% | 147.13% |
| Cash from Operations | 96.70% | 56.12% | 1,575.62% | 28,615.13% | 309.14% |
| Capital Expenditure | 97.16% | 66.60% | -58.21% | -2,146.58% | -2,355.16% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -100.00% | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.09% | 78.47% | 51.94% | -29.35% | 5.78% |
| Cash from Investing | 66.40% | 62.07% | 16.10% | -126.48% | -93.68% |
| Total Debt Issued | -100.00% | -100.00% | -100.00% | -58.25% | -58.25% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 71.89% | 72.10% | -95.85% | -51.27% | -333.29% |
| Cash from Financing | -117.51% | -105.79% | -111.91% | -48.82% | -58.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 238.17% | -114.23% | -139.72% | -93.47% | -113.32% |